New COVID-19 Vaccine Rules Spark Access Concerns
US regulators have approved updated COVID-19 vaccines, restricting availability largely to seniors and high-risk groups. The FDA revoked Pfizer's shot for children under 5, creating barriers for many Americans seeking vaccination. The shift reflects doubts about yearly booster needs and complicates vaccine access across the nation.
- Country:
- United States
US regulators have authorized updated COVID-19 vaccines while narrowing their availability for many Americans. The Food and Drug Administration (FDA) has approved new shots from Pfizer, Moderna, and Novavax, focusing on seniors and individuals with high-risk conditions like asthma or obesity.
The new restrictions signify a shift from previous policies that recommended annual vaccinations for all. Parents will need to consult with physicians as Pfizer's shot will no longer be available for children under 5. Despite approvals, access remains complex and could require out-of-pocket payments if insurance coverage is unavailable.
The FDA's plan highlights a growing skepticism over yearly booster shots. Although barriers to vaccines arise for healthy individuals, some experts assert the change aligns with the existing protection levels from prior vaccinations. Implementing the new policies, however, poses logistical challenges in states and among healthcare providers.
(With inputs from agencies.)
- READ MORE ON:
- COVID-19
- vaccines
- FDA
- Pfizer
- Moderna
- Novavax
- public health
- regulation
- access
- booster shots
Google News